← Back to headlines
Scinai Immunotherapeutics receives Nasdaq notice over minimum bid price requirement
Scinai Immunotherapeutics has received a notice from Nasdaq regarding its non-compliance with the minimum bid price requirement.
16 Mar, 20:26 — 16 Mar, 20:26
Sources
Showing 1 of 1 sources
